113 related articles for article (PubMed ID: 34883001)
41. EPR study of the interactions between dendrimers and peptides involved in Alzheimer's and prion diseases.
Klajnert B; Cangiotti M; Calici S; Majoral JP; Caminade AM; Cladera J; Bryszewska M; Ottaviani MF
Macromol Biosci; 2007 Aug; 7(8):1065-74. PubMed ID: 17654761
[TBL] [Abstract][Full Text] [Related]
42. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR
Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932
[TBL] [Abstract][Full Text] [Related]
43. Computationally efficient methodology for atomic-level characterization of dendrimer-drug complexes: a comparison of amine- and acetyl-terminated PAMAM.
Vergara-Jaque A; Comer J; Monsalve L; González-Nilo FD; Sandoval C
J Phys Chem B; 2013 Jun; 117(22):6801-13. PubMed ID: 23642174
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, crystal structure and EPR spectroscopic analysis of novel copper complexes formed from N-pyridyl-4-nitro-1,8-naphthalimide ligands.
Kitchen JA; Martinho PN; Morgan GG; Gunnlaugsson T
Dalton Trans; 2014 May; 43(17):6468-79. PubMed ID: 24619336
[TBL] [Abstract][Full Text] [Related]
45. Use of Half-Generation PAMAM Dendrimers (G0.5-G3.5) with Carboxylate End-Groups to Improve the DACHPtCl
Camacho C; Tomás H; Rodrigues J
Molecules; 2021 May; 26(10):. PubMed ID: 34069054
[TBL] [Abstract][Full Text] [Related]
46. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
[TBL] [Abstract][Full Text] [Related]
47. A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications.
Yang J; Lu W; Xiao J; Zong Q; Xu H; Yin Y; Hong H; Xu W
Acta Biomater; 2018 Oct; 79():306-316. PubMed ID: 30172067
[TBL] [Abstract][Full Text] [Related]
48. Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier.
Liu KC; Yeo Y
Mol Pharm; 2013 May; 10(5):1695-704. PubMed ID: 23510114
[TBL] [Abstract][Full Text] [Related]
49. Cotton Fabric Modified with a PAMAM Dendrimer with Encapsulated Copper Nanoparticles: Antimicrobial Activity.
Staneva D; Atanasova D; Nenova A; Vasileva-Tonkova E; Grabchev I
Materials (Basel); 2021 Dec; 14(24):. PubMed ID: 34947424
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
Madaan K; Lather V; Pandita D
Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
[TBL] [Abstract][Full Text] [Related]
51. EPR and affinity studies of mannose-TEMPO functionalized PAMAM dendrimers.
Samuelson LE; Sebby KB; Walter ED; Singel DJ; Cloninger MJ
Org Biomol Chem; 2004 Nov; 2(21):3075-9. PubMed ID: 15505710
[TBL] [Abstract][Full Text] [Related]
52. Silica nanoparticles functionalized with polyamidoamine (PAMAM) dendrimers as platforms for photoluminescence (PL) sensing of copper and cyanide ions.
Gerrans K; Luhrs A; Feider C; Margerum LD
J Colloid Interface Sci; 2016 May; 470():276-283. PubMed ID: 26962978
[TBL] [Abstract][Full Text] [Related]
53. Multifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy.
Zhang M; Guo R; Wang Y; Cao X; Shen M; Shi X
Int J Nanomedicine; 2011; 6():2337-49. PubMed ID: 22072871
[TBL] [Abstract][Full Text] [Related]
54. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
55. Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity.
Shao N; Su Y; Hu J; Zhang J; Zhang H; Cheng Y
Int J Nanomedicine; 2011; 6():3361-72. PubMed ID: 22267921
[TBL] [Abstract][Full Text] [Related]
56. Polyamidoamine dendrimer liposome-mediated survivin antisense oligonucleotide inhibits hepatic cancer cell proliferation by inducing apoptosis.
Han S; Cai Z; Peng L; Li Z; Zhou HB; Li XQ; Fang SZ; Huang ZH; Cui DX
Tumour Biol; 2014 May; 35(5):5013-9. PubMed ID: 24488668
[TBL] [Abstract][Full Text] [Related]
57. Structural studies of biologically active glycosylated polyamidoamine (PAMAM) dendrimers.
Barata TS; Shaunak S; Teo I; Zloh M; Brocchini S
J Mol Model; 2011 Aug; 17(8):2051-60. PubMed ID: 21161557
[TBL] [Abstract][Full Text] [Related]
58. Gene therapy for ovarian cancer using carbonyl reductase 1 DNA with a polyamidoamine dendrimer in mouse models.
Kobayashi A; Yokoyama Y; Osawa Y; Miura R; Mizunuma H
Cancer Gene Ther; 2016 Jan; 23(1):24-8. PubMed ID: 26584532
[TBL] [Abstract][Full Text] [Related]
59. Anticancer copper(II) phosphorus dendrimers are potent proapoptotic Bax activators.
Mignani S; El Brahmi N; Eloy L; Poupon J; Nicolas V; Steinmetz A; El Kazzouli S; Bousmina MM; Blanchard-Desce M; Caminade AM; Majoral JP; Cresteil T
Eur J Med Chem; 2017 May; 132():142-156. PubMed ID: 28350998
[TBL] [Abstract][Full Text] [Related]
60. Spectral investigation of coordination of cuprum cations and protons at PAMAM dendrimer peripherally modified with 1,8-naphthalimide units.
Grabchev I; Staneva D; Bojinov V; Betcheva R; Gregoriou V
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Aug; 70(3):532-6. PubMed ID: 17890144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
